Exposure-Response Analysis of Nivolumab in Patients With Previously Treated or Untreated Advanced Melanoma

被引：31

作者：

Bajaj, Gaurav ^{[1
]}

Gupta, Manish ^{[1
]}

Feng, Yan ^{[1
]}

Statkevich, Paul ^{[1
]}

Roy, Amit ^{[1
]}

机构：

[1] Bristol Myers Squibb, Princeton, NJ USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2017年 / 57卷 / 12期

关键词：

exposure-response; nivolumab; advanced melanoma; population pharmacokinetics; clearance; overall survival; ANTI-PD-1; ANTIBODY; OPEN-LABEL; IPILIMUMAB; DOCETAXEL; SAFETY;

D O I：

10.1002/jcph.962

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1527 / 1533

页数：7

共 27 条

[1]

[Anonymous], 2017, OPDIVO NIV US PACK I

[2]

Bajaj G, 2017, CPT-PHARMACOMET SYST, V6, P58, DOI 10.1002/psp4.12143

[3] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[4] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[5]

Cox DR., 1984, ANAL SURVIVAL DATA

[6] Rates of HER2 overexpression and trastuzumab response in Caribbean women with breast cancer [J].

Feng, Qi ;

Dietz, Donald Elmore ;

Sidhu, Gurinder Singh ;

Axiotis, Constantine A. ;

Braverman, Albert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[7]

Feng Y, 2015, CLIN PHARMACOL THER, V97, pS41

[8] Exposure-Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma [J].

Feng, Yan ;

Roy, Amit ;

Masson, Eric ;

Chen, Tai-Tsang ;

Humphrey, Rachel ;

Weber, Jeffrey S. .

CLINICAL CANCER RESEARCH, 2013, 19 (14) :3977-3986

[9]

Gastonguay M., 2004, AAPS J, V6, pW4354

[10]

Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO

← 1 2 3 →